Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.

Autor: Zhang, Bin, Jin, Renan, Xu, Junjie, Chen, Ming yu, Chen, Jiang, Zhu, Hepan, Cao, Jiasheng, Song, Chao, Yang, Zaibo, Zhang, Yewei, Liang, Xiao
Zdroj: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p505-505, 151p
Databáze: Supplemental Index